Officer/Director-Affiliated Trust Files Intent to Sell $43.1M in Astera Labs Shares
ALAB has more than doubled off its 52-week low of $84.78.
Summary
A trust associated with an officer and director of Astera Labs has filed a Form 144, indicating an intent to sell 200,000 shares valued at approximately $43.1 million, continuing a trend of significant insider sales.
Key Events · Ownership and Investor Activity · ALAB
-
Proposed Share Sale
A trust associated with an officer and director intends to sell 200,000 shares of common stock, with an approximate market value of $43,116,000.00.
-
Filer Relationship
The Navad Trust, for whose account the shares are to be sold, is associated with an individual holding both Director and Officer positions at Astera Labs.
-
Ongoing Insider Distribution
This filing is part of a broader pattern of insider selling, with the company experiencing over $235 million in net insider sales in the last 90 days. The same trust previously sold 200,000 shares on May 7, 2026.
Analysis · ALAB · Manufacturing
A trust associated with an officer and director of Astera Labs has filed a Form 144, indicating an intent to sell 200,000 shares valued at approximately $43.1 million. This proposed sale is significant, representing a continued pattern of insider distribution, as the same trust recently sold a similar amount of shares and the company has seen over $235 million in net insider selling in the last 90 days. This ongoing selling pressure from key insiders could create an overhang on the stock.
At the time of this filing, ALAB was trading at $245.11 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $41.9B. The 52-week trading range was $84.78 to $262.90. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.